Low-Potency Antipsychotics: Levomepromazine, Melperon, and Pipamperone
Crossref DOI link: https://doi.org/10.1007/978-3-319-56015-1_416-1
Published Online: 2021-05-29
Published Print: 2021
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Morimoto, Yoshiro
Imamura, Akira
Kanegae, Shinji
Ozawa, Hiroki
Text and Data Mining valid from 2021-01-01
Version of Record valid from 2021-01-01
Chapter History
Received: 24 February 2021, 00:00:00
Accepted: 25 February 2021, 00:00:00
First Online: 29 May 2021